<- Back to digest

JOA - 2026-10-07 - Journal Article

Treatment of Vancouver B2 and B3 Periprosthetic Femoral Fractures Using a Modular Tapered Stem: Survivorship and Radiographic Outcomes at Mean 7.8-Year Follow-Up.

Chaudhry F, Bridger A, Kolhatkar K, Nannapaneni S, Ekhtiari S, Safir OA, Gross AE, Kuzyk PR

retrospective cohortLOE IVn = 46Mean 7.6 years (range 2.0–22.6 years)

Topics

arthroplasty
PMID: 42843686DOI: 10.1016/j.arth.2026.09.044View on PubMed ->

Key Takeaway

Modular tapered stem revision THA for Vancouver B2/B3 periprosthetic femoral fractures achieved 95.1% Kaplan-Meier survivorship at 15 years with a 4.3% overall revision rate.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study evaluated survivorship and clinical outcomes of modular tapered femoral stem revision THA for Vancouver B2 (67.4%) and B3 (32.6%) periprosthetic femoral fractures in 46 patients at a single institution over a 21-year period. Kaplan-Meier analysis defined failure as revision for any cause; 15-year survivorship was 95.1% (95% CI 88.7–100.0) with only four hips at risk at that time point. Overall complication rate was 13.0%, revision rate 4.3%, and 95.2% of patients remained ambulatory at final follow-up.

Key Limitation

The 15-year survivorship estimate is based on only four hips at risk, making the confidence interval artificially narrow and the point estimate clinically unreliable for long-term counseling.

Original Abstract

INTRODUCTION

Periprosthetic fractures (PPF) of the femur are a frequent complication following total hip arthroplasty (THA). Revision THA using a modular tapered stem is a common treatment strategy for these fractures. The purpose of this study was to report the survivorship and clinical outcomes of revision THA using a modular tapered femoral stem to treat PPF of the femur.

METHODS

A total of 46 patients were included from our retrospective review of revision total hip arthroplasties performed for Vancouver B2 and B3 fractures between January 2001 and December 2022. A minimum follow-up of two years was required. Among these patients, 30 (65.2%) were women, the mean age at the time of surgery was 73 years (range, 33 to 93), and the mean follow-up was 7.6 years (range, 2.0 to 22.6). Overall, 67.4% (31 of 46) patients were classified as Vancouver B2 fractures. Kaplan-Meier survivorship analysis was conducted with failure defined as revision surgery for any reason.

RESULTS

Kaplan-Meier survivorship due to all-cause failure for patients who underwent revision THA to treat PPF via a modular tapered stem was 95.1% (95% CI [confidence interval]: 88.7 to 100.0) at 15 years with four hips at risk. The overall complication rate was 13.0% (six of 46), which included dislocation (four), infection (one), and iliopsoas tendonitis (one). The overall revision rate was 4.3% (two of 46), with revisions performed for dislocation (one) and infection (one). Overall, 95.2% (40 of 42) of patients were ambulatory at final follow-up.

CONCLUSION

Our study suggests revision THA using a modular tapered femoral stem for Vancouver B2 and B3 PPF of the femur is a viable treatment option, providing excellent 10- to 15-year survivorship and radiographic outcomes with a low complication rate. Future research should evaluate patient-reported outcomes and longer-term follow-up in larger cohorts.